BFC Planning’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$224 Buy
+3
New +$221 ﹤0.01% 3347

Other funds holding KNSA

BFC Planning's KNSA Position: Q3 2026 in Review

BFC Planning opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 3 shares worth $224. The stake represents ﹤0.01% of the portfolio and ranks #3347 among its holdings.

226 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • BFC Planning held 3 shares of Kiniksa Pharmaceuticals worth $224 as of Q3 2026.
  • Kiniksa Pharmaceuticals was a new BFC Planning position in Q3 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3347 holding.
  • 226 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.